These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12570839)

  • 1. Current strategies for the development of novel antipsychotic drugs.
    Bolós J
    Mini Rev Med Chem; 2003 May; 3(3):239-51. PubMed ID: 12570839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
    Kuroki T; Nagao N; Nakahara T
    Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformationally constrained butyrophenones with affinity for dopamine (D(1), D(2), D(4)) and serotonin (5-HT(2A), 5-HT(2B), 5-HT(2C)) receptors: synthesis of aminomethylbenzo[b]furanones and their evaluation as antipsychotics.
    Raviña E; Casariego I; Masaguer CF; Fontenla JA; Montenegro GY; Rivas ME; Loza MI; Enguix MJ; Villazon M; Cadavid MI; Demontis GC
    J Med Chem; 2000 Nov; 43(24):4678-93. PubMed ID: 11101359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroleptics in geriatrics. Pharmacological criteria for a responsible choice and a correct use].
    van Wielink PS
    Tijdschr Gerontol Geriatr; 1984 Apr; 15(2):73-80. PubMed ID: 6144201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
    Meltzer HY; Huang M
    Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and molecular targets in the search for novel antipsychotics.
    Scatton B; Sanger DJ
    Behav Pharmacol; 2000 Jun; 11(3-4):243-56. PubMed ID: 11103879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT.
    Homan EJ; Copinga S; Unelius L; Jackson DM; Wikström HV; Grol CJ
    Bioorg Med Chem; 1999 Jul; 7(7):1263-71. PubMed ID: 10465402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iloperidone: a new benzisoxazole atypical antipsychotic drug. Is it novel enough to impact the crowded atypical antipsychotic market?
    Albers LJ; Musenga A; Raggi MA
    Expert Opin Investig Drugs; 2008 Jan; 17(1):61-75. PubMed ID: 18095919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new arylpiperazine antipsychotic with high D2/D3/5-HT1A/alpha 1A-adrenergic affinity and a low potential for extrapyramidal effects.
    Reitz AB; Bennett DJ; Blum PS; Codd EE; Maryanoff CA; Ortegon ME; Renzi MJ; Scott MK; Shank RP; Vaught JL
    J Med Chem; 1994 Apr; 37(8):1060-2. PubMed ID: 7909336
    [No Abstract]   [Full Text] [Related]  

  • 11. 3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents.
    Howard HR; Lowe JA; Seeger TF; Seymour PA; Zorn SH; Maloney PR; Ewing FE; Newman ME; Schmidt AW; Furman JS; Robinson GL; Jackson E; Johnson C; Morrone J
    J Med Chem; 1996 Jan; 39(1):143-8. PubMed ID: 8568801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.
    Schotte A; Janssen PF; Gommeren W; Luyten WH; Van Gompel P; Lesage AS; De Loore K; Leysen JE
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):57-73. PubMed ID: 8935801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents.
    Peprah K; Zhu XY; Eyunni SV; Setola V; Roth BL; Ablordeppey SY
    Bioorg Med Chem; 2012 Feb; 20(3):1291-7. PubMed ID: 22245230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of serotonin and dopamine receptor binding in antipsychotic efficacy.
    Richtand NM; Welge JA; Logue AD; Keck PE; Strakowski SM; McNamara RK
    Prog Brain Res; 2008; 172():155-75. PubMed ID: 18772032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
    Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
    Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Hit-and-run" actions at dopamine receptors, part 1: Mechanism of action of atypical antipsychotics.
    Stahl SM
    J Clin Psychiatry; 2001 Sep; 62(9):670-1. PubMed ID: 11681760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformationally constrained butyrophenones with mixed dopaminergic (D(2)) and serotoninergic (5-HT(2A), 5-HT(2C)) affinities: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical antipsychotics.
    Raviña E; Negreira J; Cid J; Masaguer CF; Rosa E; Rivas ME; Fontenla JA; Loza MI; Tristán H; Cadavid MI; Sanz F; Lozoya E; Carotti A; Carrieri A
    J Med Chem; 1999 Jul; 42(15):2774-97. PubMed ID: 10425088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
    Moran-Gates T; Massari C; Graulich A; Liégeois JF; Tarazi FI
    J Neurosci Res; 2006 Aug; 84(3):675-82. PubMed ID: 16810690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine vs. serotonin receptor subtypes.
    Hameg A; Bayle F; Nuss P; Dupuis P; Garay RP; Dib M
    Biochem Pharmacol; 2003 Feb; 65(3):435-40. PubMed ID: 12527336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor mechanisms in antipsychotic drug action: focus on sigma receptors.
    Snyder SH; Largent BL
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):7-15. PubMed ID: 2577720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.